Matthew C. Murphy retired from the Drug Enforcement Administration after twenty-six years, most recently serving as the Assistant Special Agent in Charge (ASAC) of the Boston Office. Mr. Murphy held many positions within the agency including assignments to the New York Field Division, DEA Academy located in Quantico, VA., Hartford Resident Office, Worcester Resident Office, as well as the Chief of Pharmaceutical Investigations while assigned to DEA Headquarters. In that capacity, Mr. Murphy coordinated the DEA internet investigation strategy and developed a first of its kind initiative utilizing administrative/regulatory authority to investigate and dismantle illegal rogue internet pharmacies. The enforcement operations “Baywatch” and “Lightening Strike” resulted in the closing of twelve rogue internet pharmacies in Florida. The success of the aforementioned operations assisted to facilitate the Ryan Haight Act legislation, passed in 2008, which placed significant restrictions regarding how internet pharmacies operate. Mr. Murphy and the team of investigators he supervised received the DEA Administrator’s Award for their efforts.
Mr. Murphy was selected for assignment as a course developer/Instructor at the DEA Academy, located in Quantico, VA. Upon his retirement from the DEA in 2011, Mr. Murphy founded the Pharma Compliance Group. The Pharma Compliance Group provides compliance services relative to the Controlled Substances Act (CSA), and the Code of Federal Regulations (CFR), to DEA registered wholesale drug manufacturers and distributors, as well as retail pharmacies.
In 2017 Mr. Murphy accepted the position of Vice President of Compliance and Security with Khiron Life Sciences, the first fully integrated medical cannabis company to be licensed in Colombia. In his current position he is responsible for developing and implementing policies and protocols to ensure the safety and integrity of the Khiron Life Sciences cannabis supply chain from seed to sale.